138 related articles for article (PubMed ID: 1356671)
1. A study of serum prolactin levels in schizophrenia: comparison of males and females.
Kuruvilla A; Peedicayil J; Srikrishna G; Kuruvilla K; Kanagasabapathy AS
Clin Exp Pharmacol Physiol; 1992 Sep; 19(9):603-6. PubMed ID: 1356671
[TBL] [Abstract][Full Text] [Related]
2. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
Faraone SV; Brown WA; Laughren TP
J Clin Psychiatry; 1987 Apr; 48(4):151-4. PubMed ID: 2881923
[TBL] [Abstract][Full Text] [Related]
3. Basal and stimulated levels of prolactin, TSH and LH in serum of chronic schizophrenic patients, long-term treated with neuroleptics.
Naber D; Ackenheil M; Laakman G; Fischer H; von Werder K
Pharmakopsychiatr Neuropsychopharmakol; 1980 Nov; 13(6):325-30. PubMed ID: 6111094
[TBL] [Abstract][Full Text] [Related]
4. Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients.
Csernansky JG; Kaplan J; Holman CA; Hollister LE
Psychopharmacology (Berl); 1983; 81(2):115-8. PubMed ID: 6138793
[TBL] [Abstract][Full Text] [Related]
5. Basal and stimulated levels of prolactin, TSH, and LH in serum of chronic schizophrenic patients long-term treated with neuroleptics: relations to psychopathology.
Naber D; Ackenheil M; Laakmann G
Adv Biochem Psychopharmacol; 1980; 24():419-23. PubMed ID: 6105792
[TBL] [Abstract][Full Text] [Related]
6. Prolactin bioassay in schizophrenia before and after neuroleptics.
Peabody CA; Warner MD; Griffin M; Boutros NN; Worsley IG; Friesen HG
Psychiatry Res; 1992 Mar; 41(3):249-55. PubMed ID: 1594711
[TBL] [Abstract][Full Text] [Related]
7. Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response.
Meltzer HY; Busch DA; Fang VS
Psychiatry Res; 1983 Aug; 9(4):271-83. PubMed ID: 6580660
[TBL] [Abstract][Full Text] [Related]
8. Gender-specific prolactin response to antipsychotic treatments with risperidone and olanzapine and its relationship to drug concentrations in patients with acutely exacerbated schizophrenia.
Yasui-Furukori N; Saito M; Nakagami T; Sugawara N; Sato Y; Tsuchimine S; Furukori H; Kaneko S
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):537-40. PubMed ID: 20170699
[TBL] [Abstract][Full Text] [Related]
9. Prolactin shifts after neuroleptic withdrawal.
Green AI; Faraone SV; Brown WA
Psychiatry Res; 1990 Jun; 32(3):213-9. PubMed ID: 1975101
[TBL] [Abstract][Full Text] [Related]
10. Serum prolactin levels, plasma risperidone levels, polymorphism of cytochrome P450 2D6 and clinical response in patients with schizophrenia.
Wang L; Yu L; Zhang AP; Fang C; Du J; Gu NF; Qin SY; Feng GY; Li XW; Xing QH; He L
J Psychopharmacol; 2007 Nov; 21(8):837-42. PubMed ID: 17715206
[TBL] [Abstract][Full Text] [Related]
11. Tolerance to the prolactin-elevating effect of neuroleptics.
Brown WA; Laughren TP
Psychiatry Res; 1981 Dec; 5(3):317-22. PubMed ID: 6119716
[TBL] [Abstract][Full Text] [Related]
12. Relation between serum prolactin levels and antipsychotic response to risperidone in patients with schizophrenia.
Charan A; Shewade DG; Rajkumar RP; Chandrasekaran A
Psychiatry Res; 2016 Jun; 240():209-213. PubMed ID: 27111215
[TBL] [Abstract][Full Text] [Related]
13. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
[TBL] [Abstract][Full Text] [Related]
14. Stability of serum neuroleptic and prolactin concentrations during short- and long-term treatment of schizophrenic patients.
Rao ML; Brown WA
Psychopharmacology (Berl); 1987; 93(2):237-42. PubMed ID: 2892222
[TBL] [Abstract][Full Text] [Related]
15. No association between bone mass and prolactin levels among patients with schizophrenia.
Sugawara N; Yasui-Furukori N; Fujii A; Saito M; Sato Y; Nakagami T; Tsuchimine S; Kaneko S
Hum Psychopharmacol; 2011 Dec; 26(8):596-601. PubMed ID: 22105774
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine tests during treatment with neuroleptic drugs: I. Plasma prolactin response to chlorpromazine challenge.
Kolakowska T; Fraser S; Franklin M; Knox J
Psychopharmacology (Berl); 1981; 72(3):283-5. PubMed ID: 6111824
[TBL] [Abstract][Full Text] [Related]
17. The effect of smoking status on the plasma concentration of prolactin already elevated by risperidone treatment in schizophrenia patients.
Ohta C; Yasui-Furukori N; Furukori H; Tsuchimine S; Saito M; Nakagami T; Yoshizawa K; Kaneko S
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):573-6. PubMed ID: 21216266
[TBL] [Abstract][Full Text] [Related]
18. [The effect of propranolol, neuroleptics and their combination on serum prolactin levels of schizophrenic patients].
Elizur A; Segal Z; Yeret A; Aboo-Shach M; Ben-David M
Harefuah; 1979 Sep; 97(5-6):101-4. PubMed ID: 44254
[No Abstract] [Full Text] [Related]
19. Prolactin and neuroleptic drugs.
Green AI; Brown WA
Endocrinol Metab Clin North Am; 1988 Mar; 17(1):213-23. PubMed ID: 2897910
[TBL] [Abstract][Full Text] [Related]
20. The prolactin response to flutroline hydrochloride in schizophrenic patients.
Kurland AA; Nagaraju A; Hanlon TE; Williams TG
J Clin Pharmacol; 1983; 23(11-12):505-16. PubMed ID: 6141186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
